New warnings on next day driving after Stilnox use

People who take Zolpidem (Stilnox) may experience reduced ability to drive and use machinery the next morning, European regulators are warning.

A European Medicines Agency (EMA) review panel has decided they will “some changes” to the drugs’ product information to minimise the known risk of reduced mental alertness and impaired ability to drive and use machinery the morning after use.

A spokeswoman says the TGA is “aware of the EMA recommendation relating to changes to be made to the product information (PI) documents in Europe”, and the &ldquo

Latest

Trending